IP Library › Patent Application 11449866
Patent Application
App. No. 11/449,866

Therapeutic gestagens for the treatment of premenstrual dysphoric disorder

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/449,866
Abstract

A method of treating premenstrual dysphoric disorders comprising administering to a patient in need of such treatment daily from day 1 to day 24 3 mg of drospirenone and 0.02 mg of ethinylestradiol.

Claims (3)

1 . A method of treating premenstrual dysphoric disorders comprising administering to a patient in need of such treatment daily from day 1 to day 24 3 mg of drospirenone and 0.02 mg of ethinylestradiol.

2 . The method according to claim 1 wherein the drospirenone and the ethinylestradiol are administered together.

3 . The method according to claim 2 wherein the drospirenone and the ethinylestradiol are administered orally.

Assignments (2)
CHANGE OF NAME Recorded Nov 14, 2007
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 020110/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2007
From: FOEGH, MARIE; FRANZEN, REINHARD; EDER, WOLFGANG; FRICK, JEFF
To: SCHERING AKITIENGESELLSCHAFT
Reel/Frame 018846/0080 →